ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 1723
    RA Flare Prediction via Machine Learning and Algorithm Based on SSDM Big Data
  • Abstract Number: 1702
    RA-Related Knowledge and Skills of Rheumatology Fellows Among 20 US Academic Institutions
  • Abstract Number: 0843
    Rab4A Activation Predisposes to Hepatitis in Spontaneous and Pristane-Induced Mouse Models of Systemic Lupus Erythematosus
  • Abstract Number: 0844
    Rab4A Regulates Glomerulonephritis and Tryptophan Metabolism in Sle1.2.3. Lupus-prone Mice via Recycling of CD98
  • Abstract Number: 0006
    Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
  • Abstract Number: 0042
    Racial and Ethnic Differences in a Multiple Biochemical Measure of Rheumatoid Arthritis Disease Activity
  • Abstract Number: 1017
    Racial and Ethnic Disparities in the Risk of Preterm Birth Among Women with Systemic Lupus Erythematosus or Rheumatoid Arthritis with Varying Reference Groups
  • Abstract Number: 0055
    Racial and Sex-based Disparities in Health Care Utilization: Eye Inflammation as a Paradigm
  • Abstract Number: 0433
    Racial Disparities and New SLE-Specific Predictors of Stroke and Ischemic Heart Disease in Patients with Lupus
  • Abstract Number: 1644
    Radiographic Exclusionary Findings During Screening for Three Phase III Trials of Subcutaneous Tanezumab in Patients with Moderate to Severe Hip or Knee Osteoarthritis
  • Abstract Number: 1231
    Radiographic Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib as Monotherapy or in Combination with Methotrexate: Results at 2 Years
  • Abstract Number: 1895
    Radiographic Progression in Patients with Axial Spondyloarthritis Under Treatment with TNF Inhibitors. Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides)
  • Abstract Number: 1235
    Radiographic Progression of Structural Joint Damage over 5 Years of Baricitinib Treatment in Patients with Rheumatoid Arthritis: Results from RA-BEYOND
  • Abstract Number: 1105
    RANK-L Activity: Understanding the Pathogenesis of Erosive Osteoarthritis
  • Abstract Number: 1551
    Rapid Effect of Tofacitinib in Reducing US Joint and Tendon Inflammatory Lesions of RA Patients: Data from a 24 Weeks Longitudinal Study
  • Abstract Number: 0458
    Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force
  • Abstract Number: 1377
    Raynaud’s Phenomenon and Systemic Sclerosis in Post-9/11 Deployed Veterans Receiving Care Veterans Health Administration Care
  • Abstract Number: 1253
    Re-evaluation of the Extent of Lymphocytic Infiltration May Improve the Diagnostic Accuracy of Lip Biopsy in Primary Sjögren’s Syndrome (pSS)
  • Abstract Number: 1219
    Reaching Remission by IL-1 Inhibition in Rheumatoid Arthritis Patients with Type 2 Diabetes Improves the Glucose Homeostasis: Long-term Findings from TRACK Study, a Multicentre, Open-label, Randomised, Controlled Trial
  • Abstract Number: 0651
    Readmission Risk and Quality of Care in Patients Presenting to the Emergency Department with Gout Flares
  • Abstract Number: 1683
    Ready or Not? Measuring Readiness for Transition to Adult Care in Adolescents with JIA & jSLE
  • Abstract Number: 0227
    Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors
  • Abstract Number: 1031
    Real World Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Ixekizumab
  • Abstract Number: 0802
    Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Effectiveness
  • Abstract Number: 0803
    Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Safety
  • Abstract Number: 1381
    Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset
  • Abstract Number: 0812
    Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
  • Abstract Number: 0556
    Recent Use, Missed Doses and Discontinuation of Infliximab in New-users: Comparisons of Biosimilar and Originator Exposures
  • Abstract Number: 0452
    Recombinant Zoster Vaccine in Patients with Rheumatic Diseases: A Retrospective Study of 622 Patients
  • Abstract Number: 1088
    Recruitment Rates of Virtual Remote Research (Tele-Research) in Myositis
  • Abstract Number: 1186
    Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis
  • Abstract Number: 1187
    Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate
  • Abstract Number: 1048
    Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib
  • Abstract Number: 1425
    Reduced Risk of Cardiovascular Diseases Events with Renal Transplantation in Granulomatosis with Polyangiitis in the United States: Data from the US Renal Data System
  • Abstract Number: 0456
    Reduced Risk of Serious Pneumococcal Infection up to 10 Years After Immunization with 7-valent Conjugated Pneumococcal Vaccine in Patients with Inflammatory Arthritis
  • Abstract Number: 1965
    Reducing Delays for Biologic Medication Approval in Outpatient Rheumatology
  • Abstract Number: 0952
    Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial
  • Abstract Number: 1227
    Reduction in Peripheral CD19+ CD27- Naïve B Cells Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis Receiving Combined Treatment with Methotrexate and TNF Inhibitors
  • Abstract Number: 0881
    Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis During Certolizumab Pegol Treatment: 96-Week Results from the C-VIEW Study
  • Abstract Number: 0187
    Regional and Widespread Patterns of Non-articular Pain Are Common at RA Diagnosis and Contribute to Poor Outcomes at 12 Months: A Prospective Study of Pain Patterns in Canadians with RA
  • Abstract Number: 1489
    Relation of Pain Mechanisms to Development of Knee Pain in Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 0563
    Relation of Pain Sensitization to Isokinetic Knee Extension Torque: The MOST Study
  • Abstract Number: 1037
    Relationship Between Air Quality and Sarcoidosis Inflammatory Activity
  • Abstract Number: 1211
    Relationship Between Changes in Lipid Levels and Improvement in Disease Activity Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib Treatment: Pooled Analysis of Data from Two Phase 3 Studies
  • Abstract Number: 1600
    Relationship Between Electronic Health Record Vendor and Performance on Patient-reported Outcome Quality Measures in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry
  • Abstract Number: 0484
    Relationship Between Paraoxonase-1 Genotype, Activity, and Major Adverse Cardiovascular Events in Patients with Rheumatoid Arthritis Receiving Tofacitinib
  • Abstract Number: 0491
    Relationship Between Rheumatoid Arthritis and Pulmonary Function in the UK Biobank
  • Abstract Number: 1020
    Relationship Between Skin-related Quality of Life, Psychosocial Stress, and Race in Cutaneous Lupus Erythematosus
  • Abstract Number: 1112
    Relationship of Depth-Specific Subchondral Bone Mineral Density and Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 1337
    Relationship of the Pro12Ala Polymorphism of the PPARg Gene with Inflammatory Activity, Osteoporosis and Obesity in Patients with Psoriatic Arthritis
  • Abstract Number: 0694
    Relationships Among Adherence and Patient Outcomes in a Cognitive Behavioral Plus Physical Activity Intervention for Older Adults with Osteoarthritis and Hypertension
  • Abstract Number: 0158
    Relationships Between Disease Patterns in RA and Rheumatology Treatment
  • Abstract Number: 1872
    Relative Associations of Sociodemographic, Clinical and HLA-B Alleles with Enthesitis and Peripheral Arthritis in Patients with Ankylosing Spondylitis
  • Abstract Number: 0943
    Reliability and Validity Issues in Fibromyalgia Diagnosis
  • Abstract Number: 1168
    Reliability and Validity of a New Skin Activity Measure for Localized Scleroderma
  • Abstract Number: 1889
    Reliability and Validity of the PROMIS-29 Health Profile in Ankylosing Spondylitis Patients
  • Abstract Number: 1132
    Reliability of Virtual Sources of Education for Patients with Vasculitis
  • Abstract Number: 1375
    Remission in Axial Spondyloarthritis: Is There a Difference Between NSAIDs and Biologics in the Real Life?
  • Abstract Number: 1710
    Remote Rheumapalooza: Reboot of a Foundational Rheumatology Curriculum for Pre-Clinical Medical Students in the Era of Virtual Learning
  • Abstract Number: 1672
    Renal Activity Index for Lupus Nephritis Distinguishes Active Renal Disease Among Childhood Systemic Lupus Erythematosus Patients
  • Abstract Number: 0686
    Renal Evolution During the First Year of Urate-lowering Therapy According to Sonographic Joint Deposition: Data from the Lille-Alicante Inception Cohort
  • Abstract Number: 1515
    Renal Responder Status and Associated Clinical Variables in the Lupus Accelerating Medicines Partnership Cohort
  • Abstract Number: 1791
    Renal Tubular Complement C9 Deposition Is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis
  • Abstract Number: 0965
    Repetitive Inhalant Lipopolysaccharide Exposure in the Setting of Arthritis Induction Potentiates Pro-Fibrotic Inflammatory Lung Disease in Mice
  • Abstract Number: 1842
    Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus: Post Hoc Analyses of Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial
  • Abstract Number: 0440
    Representation of Women as Authors of Rheumatology Research Articles
  • Abstract Number: 1786
    Reproductive Health Outcomes in Women with RA and PsA
  • Abstract Number: 2045
    Resident Memory T Cells in Synovial Tissue Mediate Arthritis Flares
  • Abstract Number: 1410
    Resident Memory T Cells Persist in Joints of Anakinra-Treated Mice in Spontaneous Arthritis Model
  • Abstract Number: 0909
    Residual Disease Activity in Psoriatic Arthritis Patients Treated with Secukinumab and Adalimumab Who Achieved Remission or Low Disease Activity: Results from a Phase 3b, Randomized, Double-blinded, Active-controlled, Head-to-head Study
  • Abstract Number: 0323
    Residual Symptoms in Patients with PsA Who Are in Very Low Disease Activity According to Physician Assessments
  • Abstract Number: 0863
    Residual Treatment Burden, Desired Improvement, and Prioritized Treatment Goals in Systemic Lupus Erythematosus (SLE): Results from the SLE-UPDATE (Understanding Preferences, Disease Activity and Treatment Expectations) Survey in the United States
  • Abstract Number: 1407
    Resolvin D5 Modulates Th17/Treg Cell Differentiation and Suppresses Osteoclastogenesis
  • Abstract Number: 2034
    Resolving Phenotypic and Prognostic Differences in Interstitial Lung Disease Related to Systemic Sclerosis by Computed Tomography-based Radiomics
  • Abstract Number: 0714
    Response to Abatacept in JIA Categories: Results from the PRCSG/PRINTO JIA Abatacept Phase IV Registry
  • Abstract Number: 0904
    Response to Ixekizumab by C-reactive Protein Level in Patients with Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naïve) and COAST-W (TNF Inhibitor-Experienced) Trials at 52 Weeks
  • Abstract Number: 1554
    Response to Tocilizumab in Large Vessel Vasculitis According to the Extent of Baseline 18F-FDG Vascular Uptake
  • Abstract Number: 0361
    Response to Treatment with Ixekizumab in Patients with Active Non-Radiographic Axial Spondyloarthritis Based on HLA-B27 Status and Disease Duration
  • Abstract Number: 0869
    Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
  • Abstract Number: 0078
    Retrospective Analysis of Clinical Characteristics and Classification Criteria Performance in a Single Center Cohort of 114 Patients Diagnosed with IgG4-Related Disease
  • Abstract Number: 1141
    Reversing Seasonal Decline of T2T Outcome in RA Patients Under Double Hits by Chinese New Year and COVID-19 Epidemic via Online Interaction with SSDM
  • Abstract Number: 0093
    Review of Gastrointestinal Manifestations of Kohlmeier-Degos Disease
  • Abstract Number: 1586
    Rheum Service: Comprehensive Virtual Care During COVID-19
  • Abstract Number: 1177
    Rheumatic Diseases in Mexican Children and Their Psychosocial and Economic Impact on Caregivers
  • Abstract Number: 1759
    Rheumatoid Arthritis Affects the Ossicular Joints: A Human Otopathologic Study
  • Abstract Number: 1994
    Rheumatoid Arthritis Improvement After Exposure to an Anti-Inflammatory “ITIS” Diet Is Associated with Changes of Gut Microbiome and Systemic Metabolome
  • Abstract Number: 1761
    Rheumatoid Arthritis Inpatient Mortality: An Analysis of the National Inpatient Sample
  • Abstract Number: 0167
    Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program
  • Abstract Number: 0567
    Rheumatologist’s Perception of the Efficacy, Safety and Willingness to Prescribe Infliximab and Use Alternate Drug Supply Programs to Lower Cost of Rheumatoid Arthritis Care
  • Abstract Number: 0061
    Rheumatologists’ Attitudes Toward Palliative Care and Medical Assistance in Dying
  • Abstract Number: 0477
    Rheumatology Fellowship Program Directors in the United States: Analysis of Demographics, Educational and Scholarly Achievements
  • Abstract Number: 0615
    Rheumatology Going Digital: Developing a Rheumatology App for Use by All Patients Attending Our Department to Aid Remote Working and Self-management
  • Abstract Number: 0636
    Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic
  • Abstract Number: 0788
    Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery
  • Abstract Number: 1046
    Risk Factors Associated with Interstitial Lung Disease in Patients with RA: Findings from a Retrospective Healthcare Database Analysis
  • Abstract Number: 1694
    Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America
  • Abstract Number: 1324
    Risk Factors for Adverse Pregnancy Outcomes in Women with Spondyloarthritis: An Observational Study from Two European Multidisciplinary Pregnancy Clinics
  • Abstract Number: 1775
    Risk Factors for Adverse Pregnancy Outcomes of Women with Positive for Antiphospholipid Antibodies Treated with Conventional Therapies
  • Abstract Number: 1825
    Risk Factors for Antimalarial-Induced Retinal Toxicity in Systemic Lupus Erythematosus and Other Rheumatic Diseases
  • Abstract Number: 1947
    Risk Factors for Anxiety and Depression in Patients with Giant Cell Arteritis
  • Abstract Number: 0561
    Risk Factors for Falls Among Individuals with Knee OA: A Longitudinal Community-based Study
  • Abstract Number: 0926
    Risk Factors for Fractures and Osteoporosis Among Patients with Systemic Sclerosis in a United States Cohort
  • Abstract Number: 0544
    Risk Factors for Lumbar Vertebral Osteoporosis Do Not Reflect Factors Traditionally Associated with Osteoporosis at the Hip
  • Abstract Number: 0670
    Risk Factors for Pseudogout: An Electronic Medical Record Case-Control Study
  • Abstract Number: 0579
    Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients
  • Abstract Number: 1938
    Risk for Vision Loss and Relapse in Patients with Giant Cell Arteritis
  • Abstract Number: L02
    Risk Mitigating Behavior in People with Rheumatic Diseases or Psoriasis During the COVID-19 Pandemic Differ by Immunosuppressant Treatment Type: A Patient survey Study
  • Abstract Number: 0120
    Risk of Fracture in Patients with Different Glucocorticoid Requiring Diseases
  • Abstract Number: 0540
    Risk of Hydroxychloroquine Retinopathy in the Community
  • Abstract Number: 1001
    Risk of Malignant Melanoma and Nonmelanoma Skin Cancer in Rheumatoid Arthritis Patients Initiating Methotrexate versus Hydroxychloroquine
  • Abstract Number: 1005
    Risk of Non-vertebral Fractures Among Rheumatoid Arthritis Patients Treated with Biologic or Targeted-Synthetic DMARDs: A Multi-Database Comparative Safety Study
  • Abstract Number: 1417
    Risk of Relapse of ANCA-associated Vasculitis in Patients of 75 Years and Older: A Retrospective Study
  • Abstract Number: 0580
    Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting
  • Abstract Number: 2000
    Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine
  • Abstract Number: 0650
    Risk of Vertebral Fractures at Lateral Chest Radiographies in Patients with Gout
  • Abstract Number: 1149
    Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)
  • Abstract Number: 1051
    Rituximab for Interstitial Pneumonia with Autoimmune Features at Two Academic Medical Centers
  • Abstract Number: 0527
    Rituximab for Refractory Manifestations of the Antiphospholipid Syndrome: A Multicenter Israeli Experience
  • Abstract Number: 1578
    Rituximab Hypersensitivity in Rheumatic and Inflammatory Diseases: Role of Skin Testing
  • Abstract Number: 1438
    Rituximab Immunogenicity in ANCA-associated Vasculitis (RITUXIMAV)
  • Abstract Number: 1050
    Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center
  • Abstract Number: 0287
    RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells
  • Abstract Number: 1547
    Role of Artificial Intelligence in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis
  • Abstract Number: 0783
    Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype
  • Abstract Number: 0682
    Role of Inflammatory and Oxidative Stress Pathway Biomarkers in Renal Disease in Gout
  • Abstract Number: 0974
    Role of NR4A Nuclear Receptor Family in RA Synovial Ectopic Lymphoid Neogenesis Revealed by Single Cell Profiling
  • Abstract Number: 1513
    Role of Platelet C4d in Thrombosis and Lupus Nephritis
  • Abstract Number: 0290
    Role of Protein Tyrosine Phosphatase 1B (PTP1B) in Endothelial-to-Mesenchymal Transition (EndoMT) Promoted by Inflammation: Implications for SLE
  • Abstract Number: 0056
    Role of Socioeconomic and Cultural Factors in Racial Disparities in Disease Severity and Health Status of Patients with Axial Spondyloarthritis
  • Abstract Number: 1784
    Roles and Perspectives of Partners of Women with Rheumatoid Arthritis on Reproductive Decision Making: A Constructivist Grounded Theory Study
  • Abstract Number: 0101
    Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass
  • Abstract Number: 0139
    Routine Assessment of Patient Index Data (RAPID) 3 as a Predictor of Weight Reduction in Rheumatology Patients Undergoing Bariatric Surgery
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences